Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 4 (2007), Issue 7 (July)

1. Mist delivery of eye medication to the anterior segment.
   Am J Ophthalmol, 144(1): 137-9. [Abstract] [Full-text]
2. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
   Am J Ophthalmol, 144(1): 7-14. [Abstract] [Full-text]
3. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
   J Clin Oncol, 25(19): 2778-84. [Abstract] [Full-text]
4. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas.
   J Clin Oncol, 25(19): 2755-63. [Abstract] [Full-text]
5. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
   J Clin Oncol, 25(19): 2735-40. [Abstract] [Full-text]
6. Women seeking emergency contraceptive pills by using the internet.
   Obstet Gynecol, 110(1): 44-52. [Abstract] [Full-text]
7. Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
   J Clin Oncol, 25(19): 2664-70. [Abstract] [Full-text]
8. Multicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: results of the GETN(A)-1 trial.
   J Clin Oncol, 25(19): 2678-84. [Abstract] [Full-text]
9. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
   J Clin Oncol, 25(19): 2804-10. [Abstract] [Full-text]
10. Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma.
    Int J Cancer, 121(4): 878-83. [Abstract] [Full-text]
11. m-THPC-mediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategy.
    Int J Cancer, 121(5): 1149-55. [Abstract] [Full-text]
12. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.
    J Cell Physiol, 212(3): 710-6. [Abstract] [Full-text]
13. Variations in pulse oximetry plethysmographic waveform amplitude induced by passive leg raising in spontaneously breathing volunteers.
    Am J Emerg Med, 25(6): 637-42. [Abstract] [Full-text]
14. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis.
    J Vasc Surg, 46(1): 148-55. [Abstract] [Full-text]
15. Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation.
    J Vasc Surg, 46(1): 145-7. [Abstract] [Full-text]
16. Targeted delivery of catalase and superoxide dismutase to macrophages using folate.
    Biochem Biophys Res Commun, 360(1): 275-9. [Abstract] [Full-text]
17. Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.
    Biochem Biophys Res Commun, 360(1): 7-13. [Abstract] [Full-text]
18. Drug-polymer microparticles produced by supercritical assisted atomization.
    Biotechnol Bioeng, 97(6): 1626-37. [Abstract] [Full-text]
19. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
    Biotechnol Bioeng, 97(6): 1376-86. [Abstract] [Full-text]
20. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.
    J Natl Cancer Inst, 99(13): 998-1003. [Abstract] [Full-text]
21. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.
    J Natl Cancer Inst, 99(13): 1004-15. [Abstract] [Full-text]
22. Two percent formalin retention enemas for hemorrhagic radiation proctitis: a preliminary report.
    Dis Colon Rectum, 50(7): 1032-9. [Abstract] [Full-text]
23. Long-term functional assessment of antegrade colonic enema for combined incontinence and constipation using a modified Marsh and Kiff technique.
    Dis Colon Rectum, 50(7): 1023-31. [Abstract] [Full-text]
24. Off-label prescription of quetiapine in psychiatric disorders.
    Expert Rev Neurother, 7(7): 841-52. [Abstract] [Full-text]
25. Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.
    Health Serv Res, 42(4): 1499-519. [Abstract] [Full-text]
26. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
    Br J Haematol, 138(3): 374-81. [Abstract] [Full-text]
27. Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
    Br J Haematol, 138(3): 330-7. [Abstract] [Full-text]
28. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
    Eur J Vasc Endovasc Surg, 34(2): 232-5. [Abstract] [Full-text]
29. Management of metastatic cervical cancer: review of the literature.
    J Clin Oncol, 25(20): 2966-74. [Abstract] [Full-text]
30. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.
    J Clin Oncol, 25(20): 2909-20. [Abstract] [Full-text]
31. International perspectives, progress, and future challenges of paediatric HIV infection.
    Lancet, 370(9581): 68-80. [Abstract] [Full-text]
32. Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.
    Cancer Res, 67(13): 6400-8. [Abstract] [Full-text]
33. Crystalloid infusion rate during fluid resuscitation from acute haemorrhage.
    Br J Anaesth, 99(2): 212-7. [Abstract] [Full-text]
34. Appropriateness of antibiotic prophylaxis for major surgery in Korea.
    Infect Control Hosp Epidemiol, 28(8): 997-1002. [Abstract] [Full-text]
35. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.
    JAMA, 298(2): 179-86. [Abstract] [Full-text]
36. Preserving cardiac output with beta-adrenergic receptor blockade and inhibiting the Bezold-Jarisch reflex during resuscitation from hemorrhage.
    J Trauma, 63(1): 26-32. [Abstract] [Full-text]
37. PEGylated rosin derivatives: novel microencapsulating materials for sustained drug delivery.
    AAPS PharmSciTech, 8(2): Article 47. [Abstract] [Full-text]
38. Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.
    J Acquir Immune Defic Syndr, 45(4): 411-7. [Abstract] [Full-text]
39. A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164).
    J Acquir Immune Defic Syndr, 45(4): 418-25. [Abstract] [Full-text]
40. Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads.
    AAPS PharmSciTech, 8(2): Article 48. [Abstract] [Full-text]
41. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    J Urol, 178(2): 451-4. [Abstract] [Full-text]
42. The challenge of managing drug interactions in elderly people.
    Lancet, 370(9582): 185-91. [Abstract] [Full-text]
43. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.
    Lancet, 370(9582): 143-52. [Abstract] [Full-text]
44. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.
    Lancet, 370(9582): 135-42. [Abstract] [Full-text]
45. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
    Int J Radiat Oncol Biol Phys, 68(4): 1072-80. [Abstract] [Full-text]
46. Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy.
    Am J Clin Pathol, 128(2): 191-7. [Abstract] [Full-text]
47. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.
    J Clin Oncol, 25(21): 3158-67. [Abstract] [Full-text]
48. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    J Clin Oncol, 25(21): 3144-50. [Abstract] [Full-text]
49. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
    J Clin Oncol, 25(21): 3124-9. [Abstract] [Full-text]
50. Feasibility, efficacy and safety of CHOP-14 in elderly patients with very high-risk diffuse large B-cell lymphoma.
    Eur J Haematol, 79(2): 100-6. [Abstract] [Full-text]
51. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
    Heart, 93(8): 952-6. [Abstract] [Full-text]
52. Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
    Cancer Chemother Pharmacol, 60(4): 601-7. [Abstract] [Full-text]
53. Response to N7 induction chemotherapy in children more than one year of age diagnosed with metastatic neuroblastoma treated in UKCCSG centers.
    Pediatr Blood Cancer, 49(3): 234-9. [Abstract] [Full-text]
54. R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
    Cancer Chemother Pharmacol, 60(4): 545-53. [Abstract] [Full-text]
55. Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.
    Pediatr Blood Cancer, 49(3): 349-52. [Abstract] [Full-text]
56. Silk coatings on PLGA and alginate microspheres for protein delivery.
    Biomaterials, 28(28): 4161-9. [Abstract] [Full-text]
57. Self-assembled polyethylenimine-graft-poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs.
    Biomaterials, 28(28): 4132-42. [Abstract] [Full-text]
58. Pulsatile release of parathyroid hormone from an implantable delivery system.
    Biomaterials, 28(28): 4124-31. [Abstract] [Full-text]
59. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy.
    Biomaterials, 28(28): 4154-60. [Abstract] [Full-text]
60. Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy.
    Virus Genes, 35(2): 167-74. [Abstract] [Full-text]
61. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
    J Clin Oncol, 25(21): 3038-44. [Abstract] [Full-text]
62. Aversion to side effects in preventive medical treatment decisions.
    Br J Health Psychol, 12: 383-401. [Abstract] [Full-text]
63. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004.
    Ann Emerg Med, 50(2): 99-107. [Abstract] [Full-text]
64. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
    Nat Clin Pract Endocrinol Metab, 3(8): 584-93. [Abstract] [Full-text]
65. Myocardial infarction in adolescents.
    J Pediatr, 151(2): 150-4. [Abstract] [Full-text]
66. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.
    Ann Thorac Surg, 84(2): 393-400; discussion 400. [Abstract] [Full-text]
67. Rationale for transdermal drug administration in Alzheimer disease.
    Neurology, 69(4): S4-9. [Abstract] [Full-text]
68. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Neurology, 69(4): S14-22. [Abstract] [Full-text]
69. Pharmacists' perceptions of computerized prescriber-order-entry systems.
    Am J Health Syst Pharm, 64(15): 1626-32. [Abstract] [Full-text]
70. Liberal versus restrictive fluid management in knee arthroplasty: a randomized, double-blind study.
    Anesth Analg, 105(2): 465-74. [Abstract] [Full-text]
71. Ventilation-induced plethysmographic variations predict fluid responsiveness in ventilated postoperative cardiac surgery patients.
    Anesth Analg, 105(2): 448-52. [Abstract] [Full-text]
72. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    N Engl J Med, 357(4): 340-8. [Abstract] [Full-text]
73. Declines in breast cancer after the WHI: apparent impact of hormone therapy.
    Cancer Causes Control, 18(8): 847-52. [Abstract] [Full-text]
74. Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.
    Transfusion, 47(8): 1447-54. [Abstract] [Full-text]
75. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
    Lancet, 370(9583): 240-50. [Abstract] [Full-text]
76. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
    Lancet, 370(9583): 230-9. [Abstract] [Full-text]
77. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Endoscopy, 39(8): 679-85. [Abstract] [Full-text]
78. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration.
    Int J Pharm, 341(1): 78-84. [Abstract] [Full-text]
79. Capacity and tolerance of a new device for ocular drug delivery.
    Int J Pharm, 341(1): 152-61. [Abstract] [Full-text]
80. Crystal growth formation in melt extrudates.
    Int J Pharm, 341(1): 162-72. [Abstract] [Full-text]
81. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology.
    Int J Pharm, 341(1): 189-94. [Abstract] [Full-text]
82. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action.
    Int J Pharm, 341(1): 50-7. [Abstract] [Full-text]
83. Thermosensitive polymers: synthesis, characterization, and delivery of proteins.
    Int J Pharm, 341(1): 68-77. [Abstract] [Full-text]
84. Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b.
    Int J Pharm, 341(1): 125-33. [Abstract] [Full-text]
85. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Int J Pharm, 341(1): 105-13. [Abstract] [Full-text]
86. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery.
    Int J Pharm, 341(1): 143-51. [Abstract] [Full-text]
87. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Int J Pharm, 341(1): 230-7. [Abstract] [Full-text]
88. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Int J Pharm, 341(1): 114-24. [Abstract] [Full-text]
89. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
    Int J Pharm, 341(1): 97-104. [Abstract] [Full-text]
90. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
    Int J Pharm, 341(1): 221-9. [Abstract] [Full-text]
91. Preparation of floating microspheres for fish farming.
    Int J Pharm, 341(1): 85-90. [Abstract] [Full-text]
92. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
    Int J Pharm, 341(1): 58-67. [Abstract] [Full-text]
93. Evaluation of semi-interpenetrating polymer networks composed of chitosan and poloxamer for wound dressing application.
    Int J Pharm, 341(1): 35-43. [Abstract] [Full-text]
94. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers.
    Int J Pharm, 341(1): 215-20. [Abstract] [Full-text]
95. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
    Int J Pharm, 341(1): 238-45. [Abstract] [Full-text]
96. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Int J Pharm, 341(1): 207-14. [Abstract] [Full-text]
97. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
    Int J Pharm, 341(1): 195-206. [Abstract] [Full-text]
98. The role of membrane transporters in drug delivery to brain tumors.
    Cancer Lett, 254(1): 11-29. [Abstract] [Full-text]
99. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm.
    Stroke, 38(8): 2279-83. [Abstract] [Full-text]
100. Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion.
     Stroke, 38(8): 2270-4. [Abstract] [Full-text]
101. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
     Stroke, 38(8): 2275-8. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.